Repaglinide Tablets
Repaglinide tabletsare non-sulfonylurea insulin secretion agents and are used to treat patients with type 2 diabetes. Repaglinide tablets were listed in China in 2000, and it is a Class B drug in the National Medical Insurance List. Repaglinide tablets have been listed as a drug for diabetic patients with renal insufficiency by many guidelines at home and abroad.
Repaglinide tablets brand name: Repaglinide Tablets
Characteristic: White or off-white tablet
Specification: repaglinide 0.5mg×30 tablets, repaglinide 0.5mg×60 tablets.
Indications：
It is used for type 2 diabetes (non-insulin-dependent) patients whose hyperglycemia cannot be effectively controlled by diet control, weight loss and exercise. When metformin alone cannot effectively control hyperglycemia, repaglinide tab 0.5 mgcan be combined with metformin. Treatment should start from the adjuvant treatment of diet control and exercise to reduce blood sugar during meals.
Specifications of Repaglinide Tablets: repaglinide 0.5 mg oral tablet
Usage and Dosage, Adverse reactions, Contraindications, Precautions：
Please refer to the package insert.
Medicine Interactions:
Some drugs are known to affect glucose metabolism. Therefore, doctors should consider possible drug interactions.
In vitro studies have shown that the metabolism of Repaglinide is affected by CYP2C8 and CYP3A4. Repaglinide was found to be a substrate for active liver uptake (organic anion transporter OATP1B1).
Data from clinical studies carried out in healthy volunteers show that CYP2C8 is the main enzyme in the metabolism of Repaglinide, while CYP3A4 has limited effects. But if the effect of CYP2C8 is inhibited, the effect of CYP3A4 will be relatively enhanced. Therefore, the metabolism and clearance of Repaglinide may be changed due to the inhibition or induction of cytochrome P450. Therefore, extreme caution should be exercised when using CYP2C8 and CYP3A4 inhibitors simultaneously with Repaglinide. Drugs that inhibit OATP1B1 (such as cyclosporine) may increase the plasma concentration of Repaglinide. ( For more details, please refer to the package insert.)
Storage: Similar to the storage of glimepiride tablets, tab repaglinide should also be shaded, sealed, kept in a dry place.
Packaging:
Aluminum plastic packaging, 15 pills/plate , 2 plates/box; 15 pills/plate, 4 plates/box, 15 pills/plate, 6 plates/box
Shelf life: 24 months
Founded in 1992, Beiluis mainly engaged in the research & development, production and sales of pharmaceutical products. It is high-tech innovation company with core competence in the Beilu Pharma Contrast Media. Beilu provides complete Contrast Media products suitable for X-Ray and Magnetic Resonance Imaging (MRI), and it is the leading contrast media manufacturerin the Contrast Media field in China.
Send product request
Other supplier products
 |
CT/X-Ray Contrast Media | The main component of CT/X-ray Contrast Media is iodine. The Iodinated Contrast Media is a colorless, transparent, slightly viscous liquid. At pres... |
 |
Gadobutrol Injection/API | In 2020, Beilulaunched its macrocyclic Contrast Media- Gadobutrol Injection, it is gadolinium-based non-ionic Contrast Media, a paramagnetic Contra... |
 |
Iopamidol Injection | IopamidolInjection is the second-generation non-ionic iodinated Contrast Media launched in the global market. In 2015, Beilu firstly launched and l... |
 |
Calcobutrol | CAS No.: Molecular formula: C18H32CaN4O9 Molecular weight: 488.5461 Quality standard: CP Characteristics: White or off-white powder ... |
 |
Repaglinide Tablets | Repaglinide tabletsare non-sulfonylurea insulin secretion agents and are used to treat patients with type 2 diabetes. Repaglinide tablets were list... |
Same products
 |
Calcobutrol | Seller: Beijing Beilu Pharmaceutical Co., Ltd | Calcobutrol CAS No.: Molecular formula: C18H32CaN4O9 Molecular weight: 488.5461 Qual... |
|
|
Repaglinide Tablets | Seller: Beijing Beilu Pharmaceutical Co., Ltd | Repaglinide tabletsare non-sulfonylurea insulin secretion agents and are used to treat patients w... |
 |
MRI Contrast Media | Seller: Beijing Beilu Pharmaceutical Co., Ltd | agnetic resonance imaging Contrast Media (MRI Contrast Media), also called Magnetic resonance ima... |
|
|
Iopamidol Injection | Seller: Beijing Beilu Pharmaceutical Co., Ltd | IopamidolInjection is the second-generation non-ionic iodinated Contrast Media launched in the gl... |
 |
Iohexol Injection | Seller: Beijing Beilu Pharmaceutical Co., Ltd | Iohexol Injection is a non-ionic Contrast Media. Compared with a traditional ionic Contrast Media... |
